CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
  • About
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • Contributers

Recommended Insights

How COVID-19 will Accelerate Digital...

Jakirul Islam, Senior Vice President, Bank Asia

Sterile Processing Professional: 30 Years...

Jackie Mallatt, CRCST, Sterile Processing...

Packaging, A Key Element In Improving...

Bertrand Havrileck, Head of Corporate Pharma R&D,...

Top Biotech Developments to Watch for

Jeremy Williams, Life Science Review

What Role Does Digital Technology Play in...

Jeremy Williams, Life Science Review

Managing Risk and Minimizing the...

Timothy Korwan, Director, New Product Development...

Unlock the Power of Data

Jijo James, M.D., M.P.H., Chief Medical Officer,...

A Growing Reliance on Outsourcing Warrants...

Greg Aimi, Vice President, Team Manager, Supply...

How COVID-19 will Accelerate Digital...

Jakirul Islam, Senior Vice President, Bank Asia

Sterile Processing Professional: 30 Years...

Jackie Mallatt, CRCST, Sterile Processing...

Packaging, A Key Element In Improving...

Bertrand Havrileck, Head of Corporate Pharma R&D,...

Top Biotech Developments to Watch for

Jeremy Williams, Life Science Review

What Role Does Digital Technology Play in...

Jeremy Williams, Life Science Review

Managing Risk and Minimizing the...

Timothy Korwan, Director, New Product Development...

Unlock the Power of Data

Jijo James, M.D., M.P.H., Chief Medical Officer,...

A Growing Reliance on Outsourcing Warrants...

Greg Aimi, Vice President, Team Manager, Supply...

In Personalized Medicine Logistics, Technology = Transparency and Scalability

Scott Ohanesian, Senior VP Commercial Operations, Clinical Trial Logistics, QuickSTAT
Tweet

Supply Chain Complexity Requires Sophisticated IT Systems to Synchronize the Process


Throughout the last decade, the pharmaceutical and biotech industry has increased investments, research, and development in personalized medicine. The first-ever FDA approval of two CAR-T therapies in 2018 and the sharp increase in personalized medicine trials in the past three years will translate into a more complex supply chain.


Today, clinical trials for cell, gene, and immunotherapies are expanding to every corner of the world, which means there are more stakeholders involved in the process, from the sites to CMOs, CROs, and sponsors. As a result, the timing of patient procedures, manufacturing, logistics, chain of custody, and collection of data require an ever-increasing degree of control and oversight.


Call out: Transparency and scalability in personalized medicine supply chain logistics require seamless connectivity and communication between all stakeholders.


The personalized medicine supply chain faces many unique challenges, such as the complexity of ever-evolving regulations that vary from country-to-country, precise time requirements, and strict chain of custody. Also, since it involves the transport of highly time and temperature sensitive materials, it requires specialized packaging and monitoring devices.


From the collection of patient specimens (apheresis/leukapheresis) to the manufacturing of immunotherapy drugs, and finally to infusion, technology can provide real-time communication between medical professionals, hospitals, laboratories, sites, sponsors, and CMOs.


When it comes to personalized medicine, all supply chain logistics elements need to be perfectly synchronized. It is also critical to ensure that commodity integrity is maintained and patient security is guaranteed.


Technology can play a significant role in the orchestration of a successful, transparent, and secure supply chain based upon a robust Quality Control Process.


Logistics partners that have sophisticated IT infrastructure, capable of integration across multiple platforms, can provide all stakeholders with:


• Control and visibility of all shipments, with real-time alerts, notifications and milestones updates allowing for real-time action to ensure they are on time and within temperature transport


• Individual tracking from the point of pick up through to final delivery


• The capability to monitor Dewar orientation and a shipments exposure to light, to ensure the security of supply chain and the ability to limit expedited vaporization rates caused by a tilted LN2


• Temperature monitoring throughout transit with the capability of intervening to maintain the integrity


• Ongoing communication and connectivity to all the stakeholders


• The ability to “blind” patient information and protect patient data


• Power to download data from cellular-based GPS and temperature monitoring devices and transmit this information via EDI or API


• Infrastructure to transmit data, such as time in transit, temperature, location, patient ID, Dewar orientation, and exposure to light


• Chain of custody at every milestone, making sure that each therapy is collected and delivered to the correct patient, pre and post-manufacturing


• Scalable IT structure to support commercial growth and increased volumes, allowing sites to schedule shipments easily


Cell and gene therapy trials are highly collaborative, but it is essential to plan and execute every step precisely. Commercial success for personalized medicine depends on robust IT systems that will create a transparent, scalable and synchronized supply chain.


Weekly Brief

loading
Towards a New World Order
> <
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2022

    Top Vendors

    Current Issue
  • Clinical Stage Biopharmaceutical 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue
  • Clinical Trial Management 2022

    Top Vendors

    Current Issue

Read Also

How Regulatory has Become Strategically Important to Food andFeed Companies

Caroline Herody, Head of Global Regulatory Affairs,Chr. Hansen
How Regulatory has Become Strategically Important to Food andFeed Companies

Data Science In R&D: It Is About Culture

Philippe MARC, Executive Director, Global Head of Integrated Data Science, Novartis
Data Science In R&D: It Is About Culture

Partnering With A Cdmo For Successful Late Phase Biologic Drug Product Development And Launch

Roman Mathaes, Head of Pharmaceutical Services and Cristina GrigoreCristina Grigore, at Lonza
Partnering With A Cdmo For Successful Late Phase Biologic Drug Product Development And Launch

Leading Global Cdmo, Pci Has Further Expanded Its European Biotech Packaging Capabilities With Investment Across Europe In Both The Uk And Ireland Facilities

Chris Dobbs, CEng., MIET, Head of Technical Engineering, PCI Pharma Services
Leading Global Cdmo, Pci Has Further Expanded Its European Biotech Packaging Capabilities With Investment Across Europe In Both The Uk And Ireland Facilities
Encouraging Innovation in Healthcare in a COVID - 19 World

Encouraging Innovation in Healthcare in a COVID - 19 World

Duncan Turner, General Partner, SOSV, Managing Director, HAX
How Allogeneic Stem Cell Therapies Can Transform Prospects In Inherited Retinal Diseases

How Allogeneic Stem Cell Therapies Can Transform Prospects In Inherited Retinal Diseases

Gil Carrasquinho, VP Head of Cell Therapy, Santen

Optimizing Clinical Trials: Leveraging Technology To Improve Drug Development

Craig Herron, Managing Director, iSelect Fund
Optimizing Clinical Trials: Leveraging Technology To Improve Drug Development

Addressing the Expanded Role of Patient Engagement in Clinical Research

Denis Curtin, PhD, Principal, eCOA & Patient Engagement, Signant Health
Addressing the Expanded Role of Patient Engagement in Clinical Research
Loading...

Copyright © 2022 Life Science Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/cxoinsight/in-personalized-medicine-logistics-technology-transparency-and-scalability-nwid-42.html